Navigation Links
OPMI VISU 140 Surgical Microscope

ProductsOPMI VISU 140 Surgical Microscope
Company Carl Zeiss Meditec, Inc.
Item OPMI VISU 140 Surgical Microscope
Features 
  • Ready for use in a matter of seconds
  • Brighter, high-contrast red reflex
  • Focus, zoom and XY coupling - motorized for hands free operation
  • Apochromatically corrected main objective lens and zoom optics
  • Wide selection of accessories
Description Complete Cataract Competence

OPMI VISU 140 is compact, good and economical. It's everything a cataract specialist needs today.

Info Carl Zeiss Meditec, Inc.Call Carl Zeiss Meditec, Inc. to buy products (US and Canada only; other locations use number below) USACanada1-866-407-6044

Customer Service: 877-486-7473
Web site: http://www.meditec.zeiss.com/

Related medicine products :

1. No.12 Surgical Blade
2. No. SM68 Surgical Blade
3. Surgiscribe Surgical Marking Pens
4. Surgical Markers
5. TLS Surgical Markers
6. SQUEEZE-MARK Surgical Markers
7. Ultra MD40 Super Pulse CO2 Surgical Laser
8. Ultra MD 60 Super Pulse CO2 Surgical Laser
9. Ultra MD 80 Super Pulse CO2 Surgical Laser
10. Reliance Mobile Surgical Stretcher
11. Ocular Posner Diagnostic And Surgical Gonioprism
Breaking Medicine Technology:Published Data Demonstrate Arena Pharmaceuticals' Lorcaserin Has Low Abuse Potential 2Published Data Demonstrate Arena Pharmaceuticals' Lorcaserin Has Low Abuse Potential 3Published Data Demonstrate Arena Pharmaceuticals' Lorcaserin Has Low Abuse Potential 4ARKRAY, Inc. Receives FDA 510k Clearance on the Assure(R) Platinum Auto-Code Blood Glucose Monitoring System 2FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 2FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 3FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 4For Millions With Untreated Hearing Loss Holiday Season Can be Especially Difficult 6542 1For Millions With Untreated Hearing Loss Holiday Season Can be Especially Difficult 6542 2Crosstalk between critical cell signaling pathways holds clues to tumor invasion and metastasis 62132 1Crosstalk between critical cell signaling pathways holds clues to tumor invasion and metastasis 62132 2Crosstalk between critical cell signaling pathways holds clues to tumor invasion and metastasis 62132 3Tailor made HIV AIDS treatment closer to reality 62127 1Tailor made HIV AIDS treatment closer to reality 62127 2